Literature DB >> 27807353

Anticancer drugs: Translating the undruggable target.

Anna Dart1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27807353     DOI: 10.1038/nrd.2016.214

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma.

Authors:  Eli M Wallace; James P Rizzi; Guangzhou Han; Paul M Wehn; Zhaodan Cao; Xinlin Du; Tzuling Cheng; Robert M Czerwinski; Darryl D Dixon; Barry S Goggin; Jonas A Grina; Megan M Halfmann; Melissa A Maddie; Sarah R Olive; Stephen T Schlachter; Huiling Tan; Bin Wang; Keshi Wang; Shanhai Xie; Rui Xu; Hanbiao Yang; John A Josey
Journal:  Cancer Res       Date:  2016-09-06       Impact factor: 12.701

2.  Targeting renal cell carcinoma with a HIF-2 antagonist.

Authors:  Wenfang Chen; Haley Hill; Alana Christie; Min Soo Kim; Eboni Holloman; Andrea Pavia-Jimenez; Farrah Homayoun; Yuanqing Ma; Nirav Patel; Paul Yell; Guiyang Hao; Qurratulain Yousuf; Allison Joyce; Ivan Pedrosa; Heather Geiger; He Zhang; Jenny Chang; Kevin H Gardner; Richard K Bruick; Catherine Reeves; Tae Hyun Hwang; Kevin Courtney; Eugene Frenkel; Xiankai Sun; Naseem Zojwalla; Tai Wong; James P Rizzi; Eli M Wallace; John A Josey; Yang Xie; Xian-Jin Xie; Payal Kapur; Renée M McKay; James Brugarolas
Journal:  Nature       Date:  2016-09-05       Impact factor: 49.962

3.  On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models.

Authors:  Hyejin Cho; Xinlin Du; James P Rizzi; Ella Liberzon; Abhishek A Chakraborty; Wenhua Gao; Ingrid Carvo; Sabina Signoretti; Richard K Bruick; John A Josey; Eli M Wallace; William G Kaelin
Journal:  Nature       Date:  2016-09-05       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.